🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Needham raises Axon shares target, retains buy rating on strong Q3 results

EditorNatashya Angelica
Published 08/11/2024, 15:04
AXON
-

On Friday, Needham, a financial advisory firm, increased its stock price target for Axon Enterprise (NASDAQ:AXON) shares to $600 from the previous $525. The firm has maintained a Buy rating on the stock following Axon's robust third-quarter earnings. Axon outperformed expectations with a 5% revenue surplus, aligning with Needham's earlier predictions of over 30% revenue growth for the year 2024.

The company's management has revised its full-year 2024 revenue guidance upward, from a 29.5% year-over-year growth at the midpoint to now expecting a 32.0% increase. This optimistic adjustment is attributed to the widespread strength observed across Axon's product lines, customer segments, and geographical regions.

Notably, Axon has secured significant contracts with several U.S. Federal agencies, including the Department of Homeland Security (DHS), Internal Revenue Service (IRS), and Amtrak. These new deals come on the heels of a major win with the U.S. Border Patrol, which Needham had previously spotlighted in its forecast.

The advisory firm anticipates that Axon's U.S. Federal bookings could rise quarter-over-quarter in December, despite the usual budget spike in September, underscoring continued robust demand across various agencies.

The positive adjustments to Axon's 2024 revenue outlook were accompanied by an impressive increase in the guidance for EBITDA and adjusted EBITDA for the fiscal year. This reflects not only the company's strong performance in the third quarter but also its potential for sustained financial growth moving forward.

"In other recent news, Axon Enterprise reported remarkable Q3 earnings and revenues, although specific figures were not disclosed. The company's second quarter showcased a strong performance with revenues exceeding $500 million and new business bookings surpassing $1 billion, primarily driven by the launch of new products like TASER 10 and Axon Body 4.

In other significant developments, Axon's advanced DedroneBeyond technology received a Federal Aviation Administration waiver for beyond visual line of sight drone operations from the Campbell Police Department, enabling round-the-clock drone operations.

Analysts from Baird, and Goldman Sachs (NYSE:GS) have expressed optimism about Axon's future performance. Baird reiterated its Outperform rating and raised the price target to $460. Similarly, Goldman Sachs raised its shares price target to $441 while maintaining its Buy rating. These recent developments reflect a positive outlook for Axon Enterprise."

InvestingPro Insights

Axon Enterprise's recent performance and Needham's optimistic outlook are further supported by real-time data from InvestingPro. The company's market capitalization stands at an impressive $35.43 billion, reflecting strong investor confidence. Axon's revenue growth of 32.24% over the last twelve months aligns perfectly with management's revised guidance of 32.0% year-over-year growth for 2024, demonstrating consistent execution of their growth strategy.

InvestingPro Tips highlight Axon's financial strength and market performance. The company "holds more cash than debt on its balance sheet," which provides financial flexibility to pursue growth opportunities and weather potential economic uncertainties. Additionally, Axon has shown a "significant return over the last week" and is "trading near its 52-week high," indicating strong market momentum that complements Needham's increased price target.

These insights are just a sample of the valuable information available on InvestingPro, which offers 23 additional tips for Axon Enterprise, providing investors with a comprehensive view of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.